Skip to content

EOLS - Evolus, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchE

Evolus Inc

EOLS · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

E

EOLSEvolus Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $8.69
52-wk low: $3.86
Prev close: $5.79
Mkt cap: $568.0M
Fwd P/E: 74.6x
Beta: 1.36

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$78.0M

MI
Millennium
Israel Englander · Q2 2026 13F
$12.4M
position
P7
Point72
Steven Cohen · Q2 2026 13F

Earnings

Reported Aug 5, 2026

Earnings landed in line with what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -10.8%
Forward P/E: 74.63
Market cap: $568M

Valuation

P/S1.79
P/B53.71

Quality

Operating margin-3.9%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: EOLS
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market cap: $568.03M
Beta: 1.36

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

1.8x

P/B

53.7x

Profit margin

-10.8%

Op margin

-3.9%

ROE

-18730.0%

$10.5M

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$3.5M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for EOLS

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.09+$0.00

-$0.09 expected

Next report

What the street expects next

ROE

-18730.0%

ROA-5.4%

Growth

Beta1.36